1. Home
  2. AXTI vs XNCR Comparison

AXTI vs XNCR Comparison

Compare AXTI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$24.21

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.56

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
XNCR
Founded
1986
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
881.9M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
AXTI
XNCR
Price
$24.21
$11.56
Analyst Decision
Hold
Buy
Analyst Count
3
10
Target Price
$11.05
$22.78
AVG Volume (30 Days)
7.0M
541.0K
Earning Date
02-19-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,390,000.00
$150,132,000.00
Revenue This Year
N/A
$18.68
Revenue Next Year
$33.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
38.16
52 Week Low
$1.13
$6.92
52 Week High
$28.65
$18.69

Technical Indicators

Market Signals
Indicator
AXTI
XNCR
Relative Strength Index (RSI) 57.47 41.40
Support Level $23.60 $11.25
Resistance Level $28.65 $12.73
Average True Range (ATR) 3.25 0.78
MACD 0.43 0.08
Stochastic Oscillator 66.86 38.33

Price Performance

Historical Comparison
AXTI
XNCR

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: